Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The release of abuse-deterrent OxyContin directly coincides with the surging rates of heroin overdose deaths, according to a new working paper from researchers at the RAND Corp. and the Wharton School.
Beginning in February, New Brunswick, N.J.-based Johnson & Johnson will divulge price increases for its prescription drugs, reports The Washington Post.
Charlotte, N.C.-based SonaCare Medical earned clearance from the Food and Drug Administration for a new version of its Sonablate device.
The Food and Drug Administration granted market clearance for ResMed's AirMini device.
When a hospital acquires a physician practice, it is easy for supply chain operations to get lost in the shuffle when it comes to data transfer. Physicians' EMR and other data are often the first to transfer over, while the…
Here are six noteworthy drugs the Food and Drug Administration approved in 2016.
President-elect Donald Trump described the drug industry as "disastrous" and criticized current industry practices during a press conference on Wednesday.
Valeant Pharmaceuticals entered into two separate deals to sell off its oncology division and skin care unit for more than $2 billion, reports Bloomberg.
Sen. Chuck Grassley (R-Iowa), chairman of the Senate Judiciary Committee, hopes to achieve three major goals this year to help lower prescription drug prices.
Tideglusib, a drug previously used in Alzheimer's clinical trials, may boost the natural healing ability of teeth, according to a new study published in the journal Scientific Reports.